The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation

Abstract

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as r...

Glaucoma detection with damato multifixation campimetry online

“…9 Oculokinetic perimetry (OKP) has previously been suggested as a screening device for open-angle glaucoma in a systematic review. 10,11 The manual version of this test is performed with a chart displaying multiple, numbered fixation targets located at strategic points in relation to a central, black test stimulus, which moves through known points in the visual field as the numbers are read by the patient. [12][13][14] An automated version of OKP, the Damato Multifixation Campimeter Online (DMCO), has subsequently been developed.…”

Strategies to improve early diagnosis in glaucoma

“…For this reason, improving awareness of glaucoma in the general population is important to early diagnosis to ensure that individuals at risk undergo appropriate eye examinations. Although screening the general population for glaucoma might reduce incidences of late presentation (Ramesh et al, 2010), at present there is no single effective screening test, largely due to the wide variation in normal (Boland et al, 2013;Burr et al, 2007). Nevertheless, while population screening is not cost effective, the targeted screening of high-risk groups may be cost effective (e.g., those with African ancestry or family history of glaucoma).…”

“…Nevertheless, while population screening is not cost effective, the targeted screening of high-risk groups may be cost effective (e.g., those with African ancestry or family history of glaucoma). Furthermore, in the future, a technology-based first assessment could be used to obtain an initial automated probability of disease to determine those requiring more detailed examination (Burr et al, 2007).…”

Glaucoma: an area of darkness

“…As will be discussed later, severe disease at presentation prejudices the chance of the patient from avoiding visual disability from glaucoma. 19 Area and individual level deprivation were both associated with late presentation of glaucoma. Existing evidence shows that late presentation is an important risk factor for subsequent blindness.…”